Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of 1.34 is 17228% above its 5-year average of 0.01, near the high end of its 5-year range (-0.90–1.34).
216.64% above its 12-month average of 0.42.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): 0.42.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 16 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T12:10:49.387Z. Historical observations retain their original dates. Historical series through 2026-10-05.
EARNINGS PER SHARE (EPS)
1.34
EARNINGS PER SHARE (EPS) AVG TTM
0.42
EARNINGS PER SHARE (EPS) AVG 3Y
-0.09
EARNINGS PER SHARE (EPS) AVG 5Y
0.01
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+216.64%
CURRENT VS 3Y AVG
+1574.15%
CURRENT VS 5Y AVG
+17227.59%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
BrightSpring Health Services, Inc. Common Stock
Market Cap
$12.17B
Earnings Per Share (EPS)
1.34
TTM Avg
0.42
3Y Avg
-0.09
5Y Avg
0.01
Market Cap
$12.00B
Earnings Per Share (EPS)
6.14
TTM Avg
5.08
3Y Avg
4.10
5Y Avg
3.91
Market Cap
$12.49B
Earnings Per Share (EPS)
4.07
TTM Avg
2.47
3Y Avg
1.81
5Y Avg
1.14
Market Cap
$12.52B
Earnings Per Share (EPS)
-2.04
TTM Avg
-1.51
3Y Avg
-0.65
5Y Avg
0.36
Market Cap
$12.89B
Earnings Per Share (EPS)
4.26
TTM Avg
6.26
3Y Avg
6.54
5Y Avg
5.79
Market Cap
$12.95B
Earnings Per Share (EPS)
-3.58
TTM Avg
-3.33
3Y Avg
-3.49
5Y Avg
-3.66
Market Cap
$11.36B
Earnings Per Share (EPS)
1.16
TTM Avg
0.82
3Y Avg
1.13
5Y Avg
1.19
Market Cap
$13.19B
Earnings Per Share (EPS)
0.42
TTM Avg
1.15
3Y Avg
1.07
5Y Avg
1.03
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BrightSpring Health Services, Inc. Common Stock (BTSG) | $12.17B | 1.34 | 0.42 | -0.09 | 0.01 |
| Encompass Health Corporation (EHC)vs › | $12.00B | 6.14 | 5.08 | 4.10 | 3.91 |
| Penumbra, Inc. (PEN)vs › | $12.49B | 4.07 | 2.47 | 1.81 | 1.14 |
| Baxter International Inc. (BAX)vs › | $12.52B | -2.04 | -1.51 | -0.65 | 0.36 |
| DaVita Inc. (DVA)vs › | $11.47B | 11.38 | 10.37 | 8.56 | 8.35 |
| ICON Public Limited Company (ICLR)vs › | $12.89B | 4.26 | 6.26 | 6.54 | 5.79 |
| BridgeBio Pharma, Inc. (BBIO)vs › | $12.95B | -3.58 | -3.33 | -3.49 | -3.66 |
| Bio-Techne Corporation (TECH)vs › | $11.36B | 1.16 | 0.82 | 1.13 | 1.19 |
| Corcept Therapeutics Incorporated (CORT)vs › | $13.19B | 0.42 | 1.15 | 1.07 | 1.03 |
| BioMarin Pharmaceutical Inc. (BMRN)vs › | $11.12B | 0.39 | 2.04 | 1.43 | 1.69 |
Trailing EPS (TTM)
$1.34
Forward EPS (Est.)
$1.82
P/E Ratio
46.3
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | 0.94 |
| 2024-12-31 | -0.09 |
| 2023-12-31 | -0.90 |
| 2022-12-31 | -0.31 |
| 2021-12-31 | 0.29 |
| 2020-12-31 | 0.12 |
| 2019-12-31 | -0.42 |
| 2018-12-31 | -0.04 |
(FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown Quote observation: 2026-10-06T12:10:49.387Z. Historical observations retain their original dates. Historical series through 2026-10-05.
